ETFChannel.com
AMGN Description — Amgen Inc

Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co.'s products include: Enbrel® (etanercept), which is used in indications for the treatment of adult patients with moderately to severely active rheumatoid arthritis, patients with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and patients with active psoriatic arthritis; and Prolia® (denosumab), which is used for the treatment of postmenopausal women with osteoporosis at high risk of fracture or multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

Company Name: 
Amgen Inc
Website: 
www.amgen.com
Sector: 
Biotechnology
Number of ETFs Holding AMGN: 
124
Total Market Value Held by ETFs: 
$13,197,613,419.35
Total Market Capitalization: 
$124,084,000,000
% of Market Cap. Held by ETFs: 
10.64%
 ETF   AMGN Weight   AMGN Amount 
 VTI   0.40%   $3,536,745,310         
 VOO   0.48%   $2,525,553,146         
 QQQ   1.39%   $1,254,376,309         
 IVV   0.48%   $981,021,245         
 VTV   0.96%   $821,647,006         
 IBB   7.35%   $533,576,189         
 VYM   1.24%   $458,533,732         
 IWF   0.76%   $371,042,314         
 VHT   2.92%   $328,247,564         
 QUAL   1.52%   $254,063,903         
List of all 124 ETFs holding AMGN »
Quotes delayed 20 minutes

Buy (2.89 out of 4)
33rd percentile
(ranked lower than approx. 67% of all stocks covered)

Analysts Forecast:
AMGN Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding AMGN | Amgen Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.